{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:20:22Z","timestamp":1789392022292,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd010623","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000}}],"reference-count":90,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010623.pub2","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T04:09:48Z","timestamp":1422936588000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions"],"prefix":"10.1002","volume":"2014","author":[{"given":"Huan","family":"Song","sequence":"first","affiliation":[{"name":"Karolinska Institutet; Department of Medical Epidemiology and Biostatistics; Box 281 Stockholm Sweden SE-17177"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shandong Provincial Hospital Affiliated to Shandong University; Department of Orthopaedics; No.324, Jingwu Road Jinan Shandong China 250021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DongHao","family":"Lu","sequence":"additional","affiliation":[{"name":"Karolinska Institutet; Department of Medical Epidemiology and Biostatistics; Box 281 Stockholm Sweden SE-17177"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD010623.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/gut.35.5.590","article-title":"Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety","volume":"35","author":"Dent","year":"1994","journal-title":"Gut"},{"issue":"10","key":"10.1002\/14651858.CD010623.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/apt.12052","article-title":"Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial","volume":"36","author":"Fiocca","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD010623.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2036.1996.14156000.x","article-title":"Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis","volume":"10","author":"Gough","year":"1996","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD010623.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0016-5085(94)90531-2","article-title":"Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group","volume":"107","author":"Hallerb\u00e4ck","year":"1994","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD010623.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2003.07489.x","article-title":"Effects of 6-12 months of esomeprazole treatment on the gastric mucosa","volume":"98","author":"Genta","year":"2003","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD010623.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2003.07489.x","article-title":"Effects of 6-12 months of esomeprazole treatment on the gastric mucosa","volume":"98","author":"Genta","year":"2003","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD010623.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1572-0241.2001.03443.x","article-title":"Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"96","author":"Johnson","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD010623.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/gast.1999.0029900319","article-title":"Lack of effect of acid suppression therapy on gastric atrophy","volume":"117","author":"Lundell","year":"1999","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD010623.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2003.07489.x","article-title":"Effects of 6-12 months of esomeprazole treatment on the gastric mucosa","volume":"98","author":"Genta","year":"2003","journal-title":"American Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD010623.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1046\/j.1365-2036.2001.01024.x","article-title":"The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety","volume":"5","author":"Vakil","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4 part 2","key":"10.1002\/14651858.CD010623.pub2-BIB0011|cit11","first-page":"G0731","article-title":"Evolution of Helicobacter pylori infection, gastritis and enterochromaffine-like cell hyperplasia in 443 patients with gastroesophageal reflux disease treated for one year with rabeprazole","volume":"16","author":"Gardner","year":"1999","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD010623.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2036.2006.02792.x","article-title":"Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial","volume":"23","author":"Lundell","year":"2006","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD010623.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2036.1998.00370.x","article-title":"Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease","volume":"12","author":"Meining","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD010623.pub2-BIB0014|cit14","first-page":"117","article-title":"Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus","volume":"30","author":"Nishi","year":"2005","journal-title":"Tokai Journal of Experimental and Clinical Medicine"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"A232","DOI":"10.1016\/S0016-5085(03)81164-2","article-title":"Comparison of the clinical efficacy and safety of pantoprazole vs ranitidin over three years to prevent relapse in patients with healed erosive esophagitis","volume":"124","author":"Richter","year":"2003","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD010623.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MOG.0b013e328358d5b9","article-title":"Proton pump inhibitors: potential adverse effects","volume":"28","author":"Abraham","year":"2012","journal-title":"Current Opinion in Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD010623.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archinte.160.10.1455","article-title":"Superiority of lansoprazole vs. ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study","volume":"160","author":"Agrawal","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"10","key":"10.1002\/14651858.CD010623.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.amjmed.2009.04.014","article-title":"Long-term\u00a0safety\u00a0concerns\u00a0with proton pump inhibitors","volume":"112","author":"Ali","year":"2009","journal-title":"American\u00a0Journal of Medicine"},{"issue":"17","key":"10.1002\/14651858.CD010623.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2010.496","article-title":"Age-specific trends in incidence of noncardia gastric cancer in US adults","volume":"303","author":"Anderson","year":"2010","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD010623.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10654-008-9275-x","article-title":"Changes\u00a0in the\u00a0prevalence\u00a0of\u00a0dyspepsia\u00a0and\u00a0Helicobacter pylori\u00a0infection\u00a0after\u00a017\u00a0years: the S\u00f8rreisa\u00a0gastrointestinal disorder\u00a0study","volume":"23","author":"Asfeldt","year":"2008","journal-title":"European\u00a0Journal of Epidemiology"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0021|cit21","volume-title":"Introduction to Meta-Analysis (Statistics in Practice)","author":"Borenstein","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD010623.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2012.05106.x","article-title":"Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease","volume":"36","author":"Brunner","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD010623.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2036.2006.02825.x","article-title":"Continuous\u00a0treatment\u00a0of\u00a0Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence","volume":"23","author":"Cooper","year":"2006","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"24","key":"10.1002\/14651858.CD010623.pub2-BIB0024|cit24","first-page":"6735","article-title":"Human\u00a0gastric\u00a0carcinogenesis: a multistep and multifactorial process - First American Cancer\u00a0Society Award Lecture on\u00a0Cancer\u00a0Epidemiology and Prevention","volume":"52","author":"Correa","year":"1992","journal-title":"Cancer Research"},{"issue":"1","key":"10.1002\/14651858.CD010623.pub2-BIB0025|cit25","first-page":"7","article-title":"Gastroesophageal reflux disease: pathophysiology and pharmacology overview","volume":"11","author":"Dajani","year":"2000","journal-title":"Journal of the Association for Academic Minority Physicians"},{"issue":"2","key":"10.1002\/14651858.CD010623.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2036.1999.00449.x","article-title":"Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study","volume":"13","author":"Dekkers","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD010623.pub2-BIB0027|cit27","first-page":"74","article-title":"Management of precancerous conditions and lesions in the stomach\u00a0(MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)","volume":"44","author":"Dinis-Ribeiro","year":"2011","journal-title":"Endoscopy"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"American Journal of Surgical Pathology"},{"issue":"3","key":"10.1002\/14651858.CD010623.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/gast.1997.v112.pm9041231","article-title":"Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia","volume":"112","author":"Eissele","year":"1997","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD010623.pub2-BIB0030|cit30","first-page":"449","article-title":"Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions?","volume":"16","author":"Eslami","year":"2013","journal-title":"Archives of Iranian Medicine"},{"issue":"12","key":"10.1002\/14651858.CD010623.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"International Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD010623.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"S649","DOI":"10.1016\/S0016-5085(10)62991-5","article-title":"Exocrine and endocrine gastric mucosal changes under medical or surgical antireflux therapy. Results of a 5-yr follow up in the lotus trial","volume":"138","author":"Fiocca","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD010623.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gut.2010.229286","article-title":"Long-term proton pump inhibitor administration, H pylori and gastric cancer: lessons from the gerbil","volume":"60","author":"Fox","year":"2011","journal-title":"Gut"},{"issue":"3","key":"10.1002\/14651858.CD010623.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-121-3-199408010-00012","article-title":"Omeprazole, hypergastrinemia, and gastric carcinoid tumors","volume":"121","author":"Freston","year":"1994","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010623.pub2-BIB0035|cit35","first-page":"17","article-title":"Correlation\u00a0between the\u00a0prevalence\u00a0of\u00a0gastritis\u00a0and\u00a0gastric cancer\u00a0in\u00a0Japan","volume":"4","author":"Fukao","year":"1993","journal-title":"Cancer\u00a0Causes Control"},{"issue":"11","key":"10.1002\/14651858.CD010623.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1046\/j.1365-2036.2001.01105.x","article-title":"Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa","volume":"15","author":"Geboes","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010623.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2036.1998.00003.x","article-title":"Review article: gastric atrophy and atrophic gastritis - nebulous concepts in search of a definition","volume":"12","author":"Genta","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD010623.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1572-0241.2003.07489.x","article-title":"Effects of 6-12 months of esomeprazole treatment on the gastric mucosa","volume":"98","author":"Genta","year":"2003","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0039|cit39","unstructured":"Jan Brozek, Andrew Oxman, Holger Sch\u00fcnemann GRADEprofiler (GRADEpro) 2008"},{"issue":"2","key":"10.1002\/14651858.CD010623.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1055\/s-2003-37013","article-title":"Reflux disease and Barrett's esophagus","volume":"35","author":"Haag","year":"2003","journal-title":"Endoscopy"},{"issue":"7","key":"10.1002\/14651858.CD010623.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1365-2036.2011.04592.x","article-title":"Gastric\u00a0histology\u00a0in\u00a0children\u00a0treated\u00a0with\u00a0proton pump inhibitors\u00a0long\u00a0term, with emphasis on enterochromaffin cell-like hyperplasia","volume":"33","author":"Hassall","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0042|cit42","volume-title":"Epidemiological Studies of Helicobacter pylori and its Relation to Cancer and Precancerous Lesions in the Upper Gastrointestinal Tract","author":"Held","year":"2004"},{"issue":"4","key":"10.1002\/14651858.CD010623.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(88)90162-X","article-title":"Healing and relapse of severe peptic esophagitis after treatment with omeprazole","volume":"95","author":"Hetzel","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0044|cit44","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD010623.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF01298864","article-title":"Omeprazole: overview and opinion","volume":"36","author":"Holt","year":"1991","journal-title":"Digestive Diseases and Sciences"},{"issue":"3","key":"10.1002\/14651858.CD010623.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1572-0241.2006.00994.x","article-title":"Normalization\u00a0of\u00a0intestinal\u00a0metaplasia\u00a0in the\u00a0esophagus\u00a0and esophagogastric junction: incidence and clinical data","volume":"102","author":"Horwhat","year":"2007","journal-title":"American Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD010623.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1053\/j.gastro.2006.04.033","article-title":"American Gastroenterological Association Institute technical review on the management of gastric subepithelial masses","volume":"130","author":"Hwang","year":"2006","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD010623.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/apt.12012","article-title":"Gastric carcinoids after long-term use of a proton pump inhibitor","volume":"31","author":"Jianu","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD010623.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cgh.2012.11.031","article-title":"Reported side effects and complications of long-term proton pump inhibitor use: dissecting the evidence","volume":"11","author":"Johnson","year":"2013","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD010623.pub2-BIB0050|cit50","first-page":"149","article-title":"A study on the relation between proton pump inhibitor and gastric giardiasis","volume":"28","author":"Kader","year":"1998","journal-title":"Journal of the Egyptian Society of Parasitology"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD010623.pub2-BIB0051|cit51","first-page":"S29-36, S61-2","article-title":"Gastric atrophy,\u00a0metaplasia, and\u00a0dysplasia: a\u00a0clinical\u00a0perspective","volume":"36","author":"Kapadia","year":"2003","journal-title":"Journal\u00a0of Clinical\u00a0Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD010623.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","article-title":"Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa","volume":"118","author":"Klinkenberg-Knol","year":"2000","journal-title":"Gastroenterology"},{"issue":"16","key":"10.1002\/14651858.CD010623.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM199604183341603","article-title":"Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication","volume":"334","author":"Kuipers","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010623.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/gut.53.1.12","article-title":"Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial","volume":"53","author":"Kuipers","year":"2004","journal-title":"Gut"},{"issue":"16","key":"10.1002\/14651858.CD010623.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.292.16.1955","article-title":"Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs","volume":"292","author":"Laheij","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD010623.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2036.2000.00768.x","article-title":"Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors","volume":"14","author":"Laine","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD010623.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000048863","article-title":"Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa","volume":"64","author":"Lamberts","year":"2001","journal-title":"Digestion"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathologica et Microbiologica Scandinavica"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0059|cit59","first-page":"A173","article-title":"Changes in the parietal cell mass after long-term therapy with high dose omeprazole in Barrett's esophagus (BE)","volume":"110","author":"Lee","year":"1996","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD010623.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of\u00a0Helicobacter\u00a0pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner\u00a0P","year":"2007","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD010623.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0016-5085(94)90749-8","article-title":"Omeprazole vs. H2-receptor antagonists in treating patients with peptic stricture and esophagitis","volume":"106","author":"Marks","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0016-5085(00)70444-6","article-title":"Omeprazole and accelerated onset of atrophic gastritis","volume":"118","author":"McColl","year":"2000","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD010623.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1523-5378.2000.00032.x","article-title":"Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression","volume":"5","author":"Moayyedi","year":"2000","journal-title":"Helicobacter"},{"issue":"7028","key":"10.1002\/14651858.CD010623.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/bmj.312.7028.414","article-title":"Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study","volume":"312","author":"Neal","year":"1996","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD010623.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199908263410902","article-title":"Surgery to cure the Zollinger-Ellison syndrome","volume":"341","author":"Norton","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010623.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gut.45.4.489","article-title":"Endoscopic regression of Barrett's oesophagus during omeprazole therapy","volume":"45","author":"Peters","year":"1999","journal-title":"Gut"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0016-5085(00)70443-4","article-title":"Omeprazole and accelerated onset of atrophic gastritis","volume":"118","author":"Pounder","year":"2000","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD010623.pub2-BIB0068|cit68","first-page":"661","article-title":"Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer","volume":"7","author":"Poynard","year":"1995","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD010623.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1440-1746.1991.tb01468.x","article-title":"The Sydney System: histological division","volume":"6","author":"Price","year":"1991","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0070|cit70","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2013"},{"issue":"6","key":"10.1002\/14651858.CD010623.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/BF02349646","article-title":"Proton-pump inhibition and gastric giardiasis: a causal or casual association?","volume":"30","author":"Reynaert","year":"1995","journal-title":"Journal of Gastroenterology"},{"issue":"4 part 2","key":"10.1002\/14651858.CD010623.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"A1299","DOI":"10.1016\/S0016-5085(00)81053-7","article-title":"Six month safety and tolerability of esomeprazole as maintenance therapy in GERD patients with healed erosive esophagitis (EE)","volume":"118","author":"Richter","year":"2000","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD010623.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00042737-200505000-00013","article-title":"Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa","volume":"17","author":"Rindi","year":"2005","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD010623.pub2-BIB0074|cit74","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002296","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","author":"Rostom","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD010623.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2036.1999.00466.x","article-title":"Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study","volume":"13","author":"Sanduleanu","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD010623.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1046\/j.1365-2036.2001.01029.x","article-title":"Double\u00a0gastric\u00a0infection\u00a0with\u00a0Helicobacter pylori\u00a0and\u00a0non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis","volume":"15","author":"Sanduleanu","year":"2001","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD010623.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2036.1998.00349.x","article-title":"Hypergastrinaemia\u00a0during\u00a0long-term\u00a0omeprazole\u00a0therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection","volume":"12","author":"Schenk","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD010623.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/gut.46.5.615","article-title":"Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy","volume":"46","author":"Schenk","year":"2000","journal-title":"Gut"},{"issue":"1","key":"10.1002\/14651858.CD010623.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1586\/egh.12.67","article-title":"Helicobacter pylori\u00a0infection in Japan","volume":"7","author":"Shiota","year":"2013","journal-title":"Expert Review\u00a0of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD010623.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/00365520600863720","article-title":"Importance of\u00a0atrophic gastritis\u00a0in diagnostics and prevention of\u00a0gastric cancer: application of plasma biomarkers","volume":"42","author":"Sipponen","year":"2007","journal-title":"Scandinavian Journal\u00a0of\u00a0Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD010623.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000199786","article-title":"Histopathological classification of nonantral gastric endocrine growths in man","volume":"41","author":"Solcia","year":"1988","journal-title":"Digestion"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010623.pub2-BIB0082|cit82","first-page":"S1","article-title":"Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis","volume":"19","author":"Solcia","year":"1995","journal-title":"American Journal of Surgical Pathology"},{"issue":"2","key":"10.1002\/14651858.CD010623.pub2-BIB0083|cit83","first-page":"71","article-title":"Proton pump inhibitors\u00a0and\u00a0gastritis","volume":"42","author":"Suzuki","year":"2008","journal-title":"Journal\u00a0of\u00a0Clinical\u00a0Biochemistry and\u00a0Nutrition"},{"issue":"19","key":"10.1002\/14651858.CD010623.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3748\/wjg.v16.i19.2323","article-title":"Safety\u00a0of the\u00a0long-term\u00a0use of proton pump inhibitors","volume":"16","author":"Thomson","year":"2010","journal-title":"World Journal\u00a0of\u00a0Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD010623.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1046\/j.1365-2036.2000.00834.x","article-title":"Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan","volume":"14","author":"Uemura","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"17","key":"10.1002\/14651858.CD010623.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199510263331703","article-title":"A comparison of five maintenance therapies for reflux esophagitis","volume":"333","author":"Vigneri","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010623.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/apha.12208","article-title":"The regulation of gastric acid secretion - clinical perspectives","volume":"210","author":"Waldum","year":"2014","journal-title":"Acta Physiologica"},{"issue":"9","key":"10.1002\/14651858.CD010623.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1046\/j.1365-2036.1999.00593.x","article-title":"Regression of columnar lined Barrett's oesophagus with omeprazole 40 mg daily: results of 5 years continuous therapy","volume":"13","author":"Wilkinson","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD010623.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(00)70004-7","article-title":"Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome","volume":"118","author":"Wolfe","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD010623.pub2-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007098.pub2","article-title":"Long term proton pump inhibitor (PPI) use and incidence of gastric (pre) malignant lesions","author":"Eslami","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010623.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T19:03:39Z","timestamp":1707159819000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010623.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Upper GI and Pancreatic Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,2]]},"references-count":90,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010623.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,2]]}}}